Cancer-related cognitive impairment
People going through cancer treatment sometimes have cognitive changes such as trouble remembering, paying attention, or thinking clearly.\n\nDrs. Judith Carroll and Kathleen Van Dyk are clinician scientists who help patients with cancer-related cognitive impairment and conduct research into what causes it, how to identify patients at risk for it, and how to reverse its effects. \n\nJudith Carroll, PhD, is Associate Professor in the Department of Psychiatry and Biobehavioral Science at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, and she\u2019s the term Endowed Chair of the George F. Solomon Professorship in Psychobiology at UCLA. She\u2019s also a Member of the Cousins Center for Psychoneuroimmunology. She received American Cancer Society funding to support her research on \u201cBiobehavioral Vulnerability to Accelerated Aging In Breast Cancer Survivors\u201d from 2016-2020.\n\nKathleen Van Dyk, PhD, is Assistant Professor in the Department of Psychiatry and Biobehavioral Science at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA, and she\u2019s a practicing neuropsychologist. She was an American Cancer Society postdoctoral fellow, studying \u201cCognitive Decline in Breast Cancer Survivors,\u201d from 2017-2019.\n\nINCIDENCE AND NATURE OF THE PROBLEM\n2:09 \u2013 What is \u201ccancer-related cognitive impairment?\u201d Is it the same as \u201cchemo brain?\u201d \n\n3:12 \u2013 How common is it?\n\n4:41 \u2013 What kind of symptoms does it produce?\n\nCONTRIBUTING FACTORS AND MECHANISMS\n6:54 \u2013 Is cancer-related cognitive impairment a side effect of cancer? Is it caused by certain treatments?\n\n12:11 \u2013 How has COVID impacted cognitive impairment among breast cancer survivors?\n\n14:22 \u2013 On the biology of aging and how cancer could accelerate the aging process\n\nTREATMENT\n17:48 \u2013 Is cancer-related cognitive impairment reversible?\n\n22:04 \u2013 On the exciting potential of sleep interventions\n\n23:54 \u2013 Understanding the effects of endocrine therapies on brain function\n\nCLOSING THOUGHTS\n\n25:42 \u2013 How ACS funding has impacted their career and research\n\n29:40 \u2013 A message they\u2019d like to share with cancer patients, survivors, and caregivers who are concerned about cancer-related cognitive impairment